Patents by Inventor Jonas WINTER

Jonas WINTER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240399582
    Abstract: A method for the safe operation of a machine, which has a movable machine part comprising a hazardous section, comprises: the movable machine part moving according to a predefined sequence program; and an environment of the hazardous section being monitored, wherein, in the event of an engagement of an object into a defined protective volume, which is dependent on the current position of the hazardous section, within the monitored environment, a safety-related reaction is triggered that comprises the movement of the movable machine part being stopped if the engagement exceeds a defined engagement threshold of the protective volume.
    Type: Application
    Filed: May 30, 2024
    Publication date: December 5, 2024
    Inventors: Christoph HANSEN, Andre BÜHLER, Thomas NEUMANN, Jonas WINTER
  • Patent number: 11052128
    Abstract: The present invention relates to stable pharmaceutical compositions which contain polypeptides having at least two antigen-binding domains and are especially suited for subcutaneous administration. The invention provides liquid compositions which minimize the formation of undesired polypeptide aggregates (dimers and/or multimers). The present invention further provides a method for minimizing the aggregation of polypeptides having antigen-binding domains in liquid compositions.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: July 6, 2021
    Assignee: AMGEN INC.
    Inventors: Carsten Olbrich, Thomas Bunte, Jonas Winter, Jörg Peters, Thomas Trill
  • Publication number: 20150335706
    Abstract: The present invention relates to stable pharmaceutical compositions which contain polypeptides having at least two antigen-binding domains and are especially suited for subcutaneous administration. The invention provides liquid compositions which minimize the formation of undesired polypeptide aggregates (dimers and/or multimers). The present invention further provides a method for minimizing the aggregation of polypeptides having antigen-binding domains in liquid compositions.
    Type: Application
    Filed: November 5, 2013
    Publication date: November 26, 2015
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Carsten OLBRICH, Thomas BUNTE, Jonas WINTER, Jörg PETERS, Thomas TRILL